NeoGenomics, Inc. (OTCBB: NGNM), a high-complexity CLIA-certified clinical laboratory, specializes in cancer genetics diagnostic testing for pathologists, oncologists, urologists, clinicians and hospitals throughout the United States. The Company’s testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry, morphology studies, anatomic pathology and molecular genetic testing. For further information, visit the Company’s Web site at www.neogenomics.com.

Noble Financial, a research driven, full-service investment banking boutique, is as discriminating with its invitations to institutional investors as it is with the companies invited to present. Rather than just focusing on crowding the conference floor, Noble Financial carefully invites a smaller audience of investors with a large appetite for the companies presenting; quality always trumps quantity. For more information or to view webcasts of today’s presentations, visit www.noblefcm.com.

Let us hear your thoughts below: